"第536/2014号法规"如何改变与治疗放射性药物的学术研究:当地经验
Valentina Di Iorio1, Stefano Boschi2, Erika Brugugnoli1
1IRCCS IRST Dino Amadori, Via Piero Maroncelli 40, 47014 Meldola, Italy.
Pharmaceuticals (Basel, Switzerland)
|November 27, 2025
概括
欧盟对试验性治疗放射性药物的新法规对学术研究产生了影响. 坚持良好的制造实践 (GMP) 需要投资,但会提高试验质量和竞争力.
科学领域:
- 核医学就是核医学.
- 放射性药物科学 放射性药物科学
- 监管事务 监管事务
背景情况:
- 在新的欧盟 (EU) 规定下,治疗放射性药物的学术研究正在发展.
- 规则 (EU) 没有. 536/2014和良好制造实践 (GMP) 准则显著影响放射性药物开发.
- 当地经验和分析对于理解这些影响至关重要.
研究的目的:
- 在欧盟监管框架内审查涉及研究治疗放射性药物的学术研究的未来.
- 讨论GMP要求对放射性药物开发的影响.
- 分析第536/2014条例对学术临床试验的影响.
主要方法:
- 对实验性药品 (IMP) 和放射性药品的良好生产规范的欧洲监管背景的分析.
- 审查科学协会的立场论文和EMA指南.
- 临床影响和监管变化的多学科团队评估.
主要成果:
- IRST有20年的经验,根据指令进行了16次试验,根据新规定进行了5次试验,招募了1000多名患者.
- 成功过渡涉及人员培训,建立合同研究组织 (CRO),预算规划,并利用合同开发和制造组织 (CDMO).
- 监管约束被转化为组织增强的机会,提高数据可靠性和加强研究能力.
结论:
- 欧盟法规536/2014对学术放射性药物研究中心产生了重大影响.
- 遵守治疗放射性药品的良好生产规范需要对基础设施和人员进行大量投资.
- 满足GMP标准为改善临床试验质量,可靠性和国际竞争力提供了机会.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.6K
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.4K
相关概念视频
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
Drug Control Governance: Regulatory Bodies and Their Impact
466
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
466
Therapeutic Drug Monitoring: Affecting Factors
183
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183
